Day 4: Innovations from academic and industrial research
The last day of the event focuses on current trends in academic and industrial research. The pandemic has driven research into and the search for new diagnostic solutions with a high sensitivity that provide rapid results, require minimal use of equipment and are ideally able to measure several biomarkers, known as multiplexing. Here, electrochemical detection systems are increasingly taking center stage in the form of biosensors. In the morning, Dr Firat Güder, Imperial College London, will present a miniaturized, electrochemical qPCR. Known as TriSilix, this lab-on-a-chip is cost-effective in production and could replace traditional qPCR systems in future.
Quest Imaging Solutions provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs
In her talk, Dr Despina Moschou, University of Bath, takes a closer look at recognizing sepsis at an early stage. This requires the precise quantification of a range of biomarkers, ideally without the use of electrochemical sensors, as these bear a risk of biological contamination. To achieve this, the planar gold electrodes on a lab-on-PCB micro system were given a new, nanocomposite coating composed of cross-linked bovine serum albumin containing a network of reduced graphene oxide nanoparticles.
The presentation by Dr. Gerhard Kahr, Genius5-Instruments GmbH, focuses on distorted sense of smell as the main symptom of Covid-19 in children. 90 percent of children with proven distorted sense of smell have Covid-19. Systematically testing the sense of smell will help recognize this distortion at an earlier stage, which will in turn help identify patients who have been infected yet do not exhibit symptoms of the disease. As these are non-contact tests, they are usually accepted by children without any problems
Dr Martin Raasch, Dynamic42 , Jena, presents a research platform for the future. As a 3D in vitro model of a human lung, this microphysiological system has integrated immune cells and helps research Covid-19 and other infectious diseases of the lung.
For more information about the MEDICA LABMED FORUM program:
Author: Gabriele Brähler, Healthcare Journalist (Berlin, Germany)Back to HCB News